A Hamm
Publications by Year
Research Areas
Child and Adolescent Psychosocial and Emotional Development, Stress Responses and Cortisol, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Thyroid Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → Neuropeptide S receptor gene — converging evidence for a role in panic disorder(2010)170 cited
- → Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well‐being and cognitive performance in hypothyroidism(2004)153 cited
- → Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia(2009)95 cited
- → Intolerance of uncertainty, social support, and loneliness in relation to anxiety and depressive symptoms among women diagnosed with ovarian cancer(2019)89 cited
- → A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety(2018)18 cited
- → Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression(2024)5 cited
- → P.4.b.023 An updated meta-analysis of classical fear conditioning in the anxiety disorders(2014)3 cited
- → Genetic variability of GLRB impact cognitive behavioral therapy response in panic disorder(2020)1 cited
- → Replacement therapy with thyroxine plus triiodothyronine (14:1) is not superior to thyroxine alone with respect to the psychical and physical wellbeing of patients with hypothyroidism(2004)1 cited
- → S.24.05 The role of genetic variation in the neuropeptide S system in anxiety disorders(2011)